SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-07-008160
Filing Date
2007-04-23
Accepted
2007-04-23 12:37:15
Documents
1
Period of Report
2007-04-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 20993
  Complete submission text file 0001140361-07-008160.txt   22850
Mailing Address 34801 CAMPUS DR FREMONT CA 94555
Business Address 34801 CAMPUS DR FREMONT CA 94555 5105741400
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 34801 CAMPUS DRIVE FREMONT CA 94555
Business Address 510-574-1400
Iwanicki David (Reporting) CIK: 0001322481 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 07780993